How GLP-1 follow-up should work

Follow-up is where clinics diverge most. Two programs with identical intakes can differ completely afterwards: one checks in at every dose step and repeats labs when they should be repeated, the other sends a refill reminder. The labels and society guidance give you enough to know which you are getting.

The rhythm the labels set

The Wegovy label starts at 0.25 mg weekly for 4 weeks and titrates every 4 weeks toward maintenance. The Zepbound label starts at 2.5 mg weekly for 4 weeks and increases in 2.5 mg steps after at least 4 weeks, choosing the maintenance dose on response and tolerability. Both labels allow a step to be delayed if you are not tolerating the current dose. So the escalation phase has a natural decision point roughly every four weeks, and each one is a question a clinician should answer with you, not a default.

A schedule to hold a clinic to

1. Week 0

   Start

   Intake complete, labs reviewed, first dose. You know who to contact and how fast they answer.

2. Week 2 (optional)

   Early tolerance check

   A message or short call: are you keeping fluids down, any injection-site issues, any questions about technique. Not required by the labels; common in well-run programs.

3. Week 4

   First titration decision

   Side effects reviewed. Decision to step up, hold, or step down. The labels allow holding; a clinic that steps up automatically is not deciding.

4. Weeks 8, 12, 16, 20

   Further steps

   Same conversation at each step. Weight, blood pressure if you have a cuff, side effects, any change in other medication. If you take insulin or a sulfonylurea, their doses reviewed each time.

5. Maintenance

   Review every 3 to 6 months

   In a room if you have conditions that need an exam or repeat labs; otherwise remote is reasonable. Review whether the plan is working, whether to continue, and what happens if you stop.

6. Any time

   Symptom escalation

   Severe persistent abdominal pain, repeated vomiting, inability to keep fluids down, signs of an allergic reaction, a lump in the neck, vision changes if diabetic. These need a same-day response and often an in-person assessment.

The intervals are the label's; the structure is editorial, consistent with the AACE/ACE 2016 guideline's expectation of follow-up on response and adverse effects.

Side effects between visits

The common reactions in both labels are gastrointestinal: nausea, diarrhea, vomiting, constipation, abdominal pain. Most are manageable, but the labels also describe what those symptoms can turn into: dehydration leading to acute kidney injury, and pancreatitis presenting as severe persistent abdominal pain sometimes radiating to the back. A clinic's follow-up plan therefore needs two tiers. A routine channel, answered in a day or two, for "the nausea is worse this week, should I hold the step". And an urgent channel, answered the same day, for the symptoms above, with a clear instruction to go to urgent care or an emergency department when appropriate. Ask on the first call what each channel is and how it is staffed at weekends.

When labs repeat

The labels do not set a lab schedule. What repeats depends on your conditions:

• Type 2 diabetes: the ADA Standards of Care 2026 recommend assessing glycemic status at least twice a year, and more often, for example every 3 months, when treatment has recently changed or goals are not met. Starting a GLP-1 is a treatment change.
• Kidney disease, or an episode of dehydration: kidney function should be rechecked; the labels' kidney warnings are the reason.
• Abnormal baseline results: whatever was abnormal gets repeated on the interval your clinician sets.
• Everything else: periodic, not monthly. A clinic that draws a full panel every month is billing, not monitoring.

The monitoring calendar at formblendslabs.com lays out typical intervals test by test, and the lab tracker lets you keep your own results side by side.

Questions that reveal the plan

1. Who reviews my progress at each dose step, and is it a person or an automatic reorder?
2. Can I hold at a dose if I am not tolerating it, and how do I tell you?
3. What symptoms do you want to hear about the same day, and how do I reach you at a weekend?
4. Which labs will you repeat, and when?
5. If you decide I need to be seen in person, where do I go?
6. What happens to my follow-up if I stop the medication? Does the membership stop too?

A clinic that answers these without hesitation has a follow-up plan. One that answers with "your subscription renews monthly" has a subscription.